DUGAN MICHAEL C 4
4 · BIOCEPT INC · Filed Sep 1, 2020
Insider Transaction Report
Form 4
BIOCEPT INCBIOC
DUGAN MICHAEL C
Chief Med Off & Med. Director
Transactions
- Award
Employee Stock Option (right to buy)
2020-08-31+54,900→ 54,900 totalExercise: $0.67Exp: 2030-08-30→ Common Stock (54,900 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (8/18/2021) with the balance vesting in equal monthly installments thereafter until fully vested on August 18, 2024.